XML 66 R48.htm IDEA: XBRL DOCUMENT v3.25.0.1
SHARE BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value of Options Granted with Assumptions
The fair value of each option award at grant date was estimated using the Black-Scholes option-pricing model with the following assumptions made and resulting grant-date fair values during the years ended December 31:
 202420232022
Weighted-average grant-date fair value
$5.47 
$1.99
$9.45
Expected term (in years)
3.5 - 4.0
 
3.3 - 4.0
3.5 - 4.5
Expected volatility
65.7% - 66.0%
 
60.1% - 60.9%
51.8% - 52.9%
Expected dividend yield
0% 0%0%
Risk-free annual interest rate
4.2%
 
4.3% - 4.5%
1.2% - 1.8%
Schedule of Number and Weighted-average Exercise Prices and Remaining Contractual Life of Options
The following table summarizes the Company's stock option activity for the year ended December 31, 2024:
 Number
of options		Weighted
average
exercise price
Outstanding options, beginning of year
4,197,058$17.73 
Granted992,16610.00 
Exercised (1)
(153,511)4.52 
Forfeited(335,620)54.03 
Expired
(64,026)19.54 
Outstanding options, end of year (2)
4,636,067$13.86 
Vested and exercisable options, end of year (3)
3,606,920$15.68 
(1) The total aggregate intrinsic value of options exercised was $1.0 million, zero, and $2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively.
(2) Outstanding options at the end of the year had a weighted average remaining contractual life of 4.0 years with a total aggregate intrinsic value of $1.7 million.
(3) Vested and exercisable options at the end of the year had a weighted average remaining contractual life of 3.6 years with a total aggregate intrinsic value of $1.2 million.
Schedule of Restricted Stock Activity
The following table summarizes the Company's RSU activity for the year ended December 31, 2024:

Restricted Stock Unit Activity
Number of
restricted stock units
Weighted-average
grant-date fair value
Unvested balance, beginning of year
2,686,216$5.47 
Granted2,194,91810.00 
Vested(1,484,742)6.83 
Forfeited(216,748)8.00 
Unvested balance, end of year
3,179,644$7.80 
Schedule of Share-Based Compensation Expense
The following table presents total share-based compensation expense for the years ended December 31:

202420232022
Statements of operations(in thousands)
Cost of goods sold$1,276 $810 $1,072 
General and administrative16,608 9,098 16,347 
Sales and marketing2,318 667 705 
Total share-based compensation expense$20,202 $10,575 $18,124